↓ Skip to main content

Dove Medical Press

VEGF siRNA delivered by polycation liposome-encapsulated calcium phosphate nanoparticles for tumor angiogenesis inhibition in breast cancer

Overview of attention for article published in International Journal of Nanomedicine, August 2017
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (61st percentile)
  • Good Attention Score compared to outputs of the same age and source (74th percentile)

Mentioned by

patent
1 patent
facebook
1 Facebook page

Citations

dimensions_citation
55 Dimensions

Readers on

mendeley
43 Mendeley
Title
VEGF siRNA delivered by polycation liposome-encapsulated calcium phosphate nanoparticles for tumor angiogenesis inhibition in breast cancer
Published in
International Journal of Nanomedicine, August 2017
DOI 10.2147/ijn.s142739
Pubmed ID
Authors

Jinliang Chen, Xiaoyi Sun, Rong Shao, Yichao Xu, Jianqing Gao, Wenquan Liang

Abstract

Angiogenesis plays an important role in tumor development and metastasis, and many cancer cells upregulate VEGF expression to promote angiogenesis. Silencing VEGF expression by RNA interference is expected to be a promising strategy to suppress the tumor growth. However, low transfection efficiency and instability are the main barriers for small interfering RNA (siRNA) delivery. In this study, we developed polycation liposome-encapsulated calcium phosphate nanoparticles (PLCP) for siRNA delivery in vivo. VEGF expression silencing effect in MCF-7 cells was investigated by real-time quantitative polymerase chain reaction and Western blot assay. VEGF siRNA mediated by PLCP can reduce 60%-80% VEGF expression in vitro, which was significantly higher than that mediated by Lipofectamine 2000. Furthermore, significant tumor growth and angiogenesis inhibition were observed in MCF-7 xenografts mice when treated with PLCP/VEGF siRNA or combined with doxorubicin. In conclusion, the combination of silencing VEGF expression and chemotherapeutics would be a potential treatment for cancer therapy.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 43 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 43 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 7 16%
Researcher 5 12%
Student > Doctoral Student 4 9%
Student > Master 4 9%
Professor > Associate Professor 3 7%
Other 5 12%
Unknown 15 35%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 7 16%
Chemistry 5 12%
Biochemistry, Genetics and Molecular Biology 3 7%
Engineering 3 7%
Agricultural and Biological Sciences 2 5%
Other 6 14%
Unknown 17 40%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 March 2022.
All research outputs
#8,264,793
of 25,382,440 outputs
Outputs from International Journal of Nanomedicine
#1,008
of 4,122 outputs
Outputs of similar age
#121,715
of 327,503 outputs
Outputs of similar age from International Journal of Nanomedicine
#25
of 99 outputs
Altmetric has tracked 25,382,440 research outputs across all sources so far. This one has received more attention than most of these and is in the 66th percentile.
So far Altmetric has tracked 4,122 research outputs from this source. They receive a mean Attention Score of 4.7. This one has gotten more attention than average, scoring higher than 74% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 327,503 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 61% of its contemporaries.
We're also able to compare this research output to 99 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 74% of its contemporaries.